These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15156101)

  • 1. Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model.
    Zhao P; Liang X; Kalbfleisch J; Koo HM; Cao B
    Hum Antibodies; 2003; 12(4):129-35. PubMed ID: 15156101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
    Staats HF; Alam SM; Scearce RM; Kirwan SM; Zhang JX; Gwinn WM; Haynes BF
    Infect Immun; 2007 Nov; 75(11):5443-52. PubMed ID: 17709410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo.
    Little SF; Webster WM; Fisher DE
    FEMS Immunol Med Microbiol; 2011 Jun; 62(1):11-22. PubMed ID: 21231965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passive vaccination with a human monoclonal antibody: generation of antibodies and studies for efficacy in Bacillus anthracis infections.
    vor dem Esche U; Huber M; Zgaga-Griesz A; Grunow R; Beyer W; Hahn U; Bessler WG
    Immunobiology; 2011 Jul; 216(7):847-53. PubMed ID: 21397977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Toxin-neutralizing monoclonal antibodies to the different domains of anthrax protective antigen].
    Xu JJ; Zhang J; Liu SL; Lv TJ; Chen W; Li GL; Ge M; Guo Q
    Wei Sheng Wu Xue Bao; 2005 Dec; 45(6):947-51. PubMed ID: 16496709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
    Nguyen ML; Crowe SR; Kurella S; Teryzan S; Cao B; Ballard JD; James JA; Farris AD
    Infect Immun; 2009 Jan; 77(1):162-9. PubMed ID: 18981257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin.
    Sapra R; Gaucher SP; Lachmann JS; Buffleben GM; Chirica GS; Comer JE; Peterson JW; Chopra AK; Singh AK
    Microb Pathog; 2006; 41(4-5):157-67. PubMed ID: 16950595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope.
    Zhang J; Xu J; Li G; Dong D; Song X; Guo Q; Zhao J; Fu L; Chen W
    Biochem Biophys Res Commun; 2006 Mar; 341(4):1164-71. PubMed ID: 16460675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.
    Lim NK; Kim JH; Oh MS; Lee S; Kim SY; Kim KS; Kang HJ; Hong HJ; Inn KS
    Infect Immun; 2005 Oct; 73(10):6547-51. PubMed ID: 16177329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal antibodies to B.anthracis protective antigen are capable to neutralize and to enhance the anthrax lethal toxin action in vitro].
    Belova EV; Dubileĭ SA; Kravchenko TB; Kolesnikov AV; Zakharova MIu; Shemiakin IG
    Mol Gen Mikrobiol Virusol; 2004; (3):21-6. PubMed ID: 15354937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera.
    Verma M; Suryanarayana N; Tuteja U; Thavachelvam K; Rao MK; Bhargava R; Shukla S
    Toxicon; 2017 Dec; 139():58-65. PubMed ID: 28919458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin.
    Huber M; Vor Dem Esche U; Grunow R; Bessler WG
    Drugs Exp Clin Res; 2005; 31(2):35-43. PubMed ID: 15929604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential susceptibility of macrophage cell lines to Bacillus anthracis-Vollum 1B.
    Gutting BW; Gaske KS; Schilling AS; Slaterbeck AF; Sobota L; Mackie RS; Buhr TL
    Toxicol In Vitro; 2005 Mar; 19(2):221-9. PubMed ID: 15649636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human/murine chimeric fab antibody neutralizes anthrax lethal toxin in vitro.
    Ding G; Chen X; Zhu J; Duesbery NS; Cheng X; Cao B
    Clin Dev Immunol; 2013; 2013():475809. PubMed ID: 23861692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen.
    Steiniger SC; Altobell LJ; Zhou B; Janda KD
    Mol Immunol; 2007 Apr; 44(10):2749-55. PubMed ID: 17210180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis.
    Cui X; Li Y; Moayeri M; Choi GH; Subramanian GM; Li X; Haley M; Fitz Y; Feng J; Banks SM; Leppla SH; Eichacker PQ
    J Infect Dis; 2005 Feb; 191(3):422-34. PubMed ID: 15633102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
    Sloat BR; Shaker DS; Le UM; Cui Z
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody.
    Li G; Qu Y; Cai C; Kong Y; Liu S; Zhang J; Zhao J; Fu L; Xu J; Chen W
    Biochem Biophys Res Commun; 2009 Aug; 385(4):591-5. PubMed ID: 19486894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of anthrax lethal factor microinjected into macrophage cells through Sendai virus envelopes.
    Swain PK; Sarkar NK; Sharma M; Goel S; Singh RP; Singh Y
    Indian J Biochem Biophys; 1997; 34(1-2):186-91. PubMed ID: 9343949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.